Medicare Enrolled
Andrew Whiteley
Internal Medicine · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Whiteley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Whiteley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Whiteley
Andrew Whiteley is an internal medicine specialist in Dallas, TX, with 15 years of NPI registration. Based on federal Medicare data, Whiteley performed 53,269 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Whiteley received a total of $1,665,815 from 57 pharmaceutical and/or device companies across 869 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Whiteley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 1% volume in TX
$1,665,815 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗53,269
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
10,710 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $137 |
| Paclitaxel chemotherapy injection | 6,208 | $0 | $8 |
| Nivolumab injection (Opdivo) | 4,360 | $24 | $76 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,598 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,399 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 830 | $1 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
787 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
726 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
698 | $92 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 560 | $0 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
396 | $10 | $64 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
276 | $23 | $157 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
254 | $13 | $60 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
246 | $17 | $60 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 219 | $3 | $373 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
218 | $103 | $707 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
183 | $12 | $108 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
182 | $6 | $31 |
| Injection, leucovorin calcium, per 50 mg | 182 | $3 | $25 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
159 | $2 | $13 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
154 | $2 | $300 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
123 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
123 | $6 | $34 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
115 | $34 | $143 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
102 | $1 | $6 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
91 | $2 | $94 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $62 | $247 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
66 | $52 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $61 | $250 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
53 | $2 | $19 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
48 | $48 | $313 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
46 | $23 | $161 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
46 | $7 | $431 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
46 | $1 | $8 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
34 | $53 | $821 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $11 | $96 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
32 | $4 | $25 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
31 | $183 | $1,067 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
31 | $55 | $207 |
| X-ray of upper arm, minimum of 2 views An X-ray imaging test of the upper arm that captures at least two different views to evaluate the bones and surrounding structures. |
30 | $18 | $67 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
29 | $16 | $94 |
| New patient office visit, complex (60-74 min) | 22 | $170 | $709 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $138 | $496 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
21 | $4 | $23 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
20 | $10 | $75 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
19 | $8 | $49 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $91 | $657 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
17 | $16 | $100 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
16 | $44 | $289 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
14 | $135 | $500 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $132 | $523 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
11 | $54 | $686 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $84 | $565 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.4% high complexity
71.0% medium
7.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,665,815
Total received (2018-2024)
Avg $237,974/year across 7 years
Top 0% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
869
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$144,187
2023
$241,350
2022
$507,633
2021
$583,067
2020
$63,074
2019
$70,770
2018
$55,733
Payments by company (2024)
BeiGene USA, Inc.
$81,946
GlaxoSmithKline, LLC.
$32,094
PFIZER INC.
$23,071
AstraZeneca Pharmaceuticals LP
$2,925
Ipsen Biopharmaceuticals, Inc
$1,725
Karyopharm Therapeutics Inc.
$835
ABBVIE INC.
$477
Genmab U.S., Inc.
$194
SOBI, INC
$189
Eli Lilly and Company
$132
Novartis Pharmaceuticals Corporation
$81
Rigel Pharmaceuticals, Inc.
$65
Lilly USA, LLC
$61
GENZYME CORPORATION
$60
Adaptive Biotechnologies Corporation
$47
Incyte Corporation
$43
ADC Therapeutics America, Inc.
$39
E.R. Squibb & Sons, L.L.C.
$34
Astellas Pharma US Inc
$31
JAZZ PHARMACEUTICALS INC.
$29
Blueprint Medicines Corporation
$28
Legend Biotech USA Inc.
$25
SERVIER PHARMACEUTICALS LLC
$21
Merck Sharp & Dohme LLC
$20
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 95.1% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$1,040,984
GlaxoSmithKline, LLC.
$191,243
BeiGene USA, Inc.
$171,503
Seattle Genetics, Inc.
$50,639
JAZZ PHARMACEUTICALS INC.
$33,270
PFIZER INC.
$29,783
Jazz Pharmaceuticals Inc.
$22,972
Agios Pharmaceuticals, Inc.
$18,205
Epizyme, Inc.,
$16,155
SOBI, INC
$13,955
Janssen Scientific Affairs, LLC
$13,548
Incyte Corporation
$7,363
CTI BioPharma Corp.
$5,128
Novartis Pharmaceuticals Corporation
$5,029
ABBVIE INC.
$4,837
GENZYME CORPORATION
$4,814
Sobi, Inc
$4,510
AbbVie Inc.
$4,356
AstraZeneca Pharmaceuticals LP
$3,527
Gilead Sciences, Inc.
$2,752
Servier Pharmaceuticals LLC
$2,535
SERVIER PHARMACEUTICALS LLC
$2,305
E.R. Squibb & Sons, L.L.C.
$2,126
Adaptive Biotechnologies Corporation
$2,061
Janssen Global Services, LLC
$2,020
Dova Pharmaceuticals
$1,818
Ipsen Biopharmaceuticals, Inc
$1,783
Karyopharm Therapeutics Inc.
$1,624
BeiGene, Ltd.
$975
Janssen Biotech, Inc.
$464
Genmab U.S., Inc.
$453
Merck Sharp & Dohme Corporation
$332
Takeda Pharmaceuticals U.S.A., Inc.
$325
Astellas Pharma US Inc
$319
Rigel Pharmaceuticals, Inc.
$228
Janssen Pharmaceuticals, Inc
$217
ADC Therapeutics America, Inc.
$203
Celgene Corporation
$182
Kite Pharma, Inc.
$150
Pharmacyclics LLC, An AbbVie Company
$150
Eli Lilly and Company
$132
Blueprint Medicines Corporation
$127
Alexion Pharmaceuticals, Inc.
$122
Heron Therapeutics, Inc.
$113
Acrotech Biopharma LLC
$91
Secura Bio, Inc.
$72
Lilly USA, LLC
$61
Stemline Therapeutics Inc.
$54
Merck Sharp & Dohme LLC
$42
Genentech USA, Inc.
$27
Legend Biotech USA Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
PharmaEssentia USA Corporation
$24
Acrotech Biopharma Inc.
$17
AbbVie, Inc.
$15
Taiho Oncology, Inc.
$14
Acceleron Pharma, Inc.
$13
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALTUVIIIO · AYVAKIT · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CALQUENCE · CHANTIX · CRESEMBA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ENJAYMO · EPKINLY · Epkinly · FARYDAK · ICLUSIG · IMBRUVICA · Imbruvica · JAKAFI · JAYPIRCA · KEYTRUDA · LIBTAYO · LONSURF · LYNPARZA · MONJUVI · MYLOTARG · NINLARO · OJJAARA · ONUREG · PEMAZYRE · PROMACTA · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SUSTOL · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · Tavalisse · Tazverik · Tibsovo · VELCADE · VENCLEXTA · VONJO · VYXEOS · Venclexta · Vonjo · XARELTO · XOSPATA · XPOVIO · Xospata · Yescarta · ZEPZELCA · ZERBAXA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,123
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Whiteley is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Whiteley experienced with iron infusion (feraheme)?
Based on Medicare claims data, Whiteley performed 10,710 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Whiteley receive payments from pharmaceutical companies?
Yes. Whiteley received a total of $1,665,815 from 57 companies across 869 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Whiteley's costs compare to other internal medicine physicians in Dallas?
Whiteley's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Whiteley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology